1 锁漉萱,张真真,万贵平,等.M2型巨噬细胞在子宫内膜异位症进展中的作用.浙江临床医学,2016,18:1552-1554. 2 Chen JM,Gao HY,Ding Y,et al.Efficacy and Safety Investigation of Kuntai Capsule for the Add-back Therapy of Gonadotropin Releasing Hormone Agonist Administration to Endometriosis Patients:a Randomized,Double-blind,Blank-and Tibolone-controlled Study.Chin Med J (Engl),2015,128:427-432. 3 李霞,刘朝霞,朱亚飞,等.M2型巨噬细胞在子宫内膜异位症中的表达及其与MVD的关系.中国妇幼保健,2012,27:2515-2519. 4 Wang J,Shen XX,Huang XH,et al.Follicular fluid levels of prostaglandin E2 and the effect of prostaglandin E2 on steroidogenesis in granulosa-lutein cells in women with moderate and severe endometriosis undergoing in vitro fertilization and embryo transfer.Chin Med J (Engl),2012,125:3985-3990. 5 王明珍,裘月红,穆琳,等.雌激素对子宫内膜异位症在位内膜间质细胞巨噬细胞移动抑制因子表达的调控作用.中国病理生理杂志,2014,11:715-718. 6 俞丹华.巨噬细胞移动抑制因子、血管生成素-2、血管内皮生长因子在子宫内膜异位症中的意义.临床和实验医学杂志,2015,10:101-103. 7 任燕,曾艳玲,李攀,等.雷公藤多甙抑制EM患者腹腔巨噬细胞及相应细胞模型分泌TNF-α的实验研究.现代中西医结合杂志,2012,21:702-704,766. 8 鲍俊峰,王红怡.IL-17、TGF-β、IFN-γ和IL-4含量在EMS患者中的表达及意义.放射免疫学杂志,2013,26:794-795. 9 Yang HL,Zhou WJ,Chang KK,et al.The crosstalk between ESC and Mφ impairs cytotoxicity of NK cell by secreting IL-10 and TGF-β in EMS.Reproduction,2017,154:815-825. 10 陈秋梅,郭华,黄艳萍,等.腹腔液白介素-6、转化生长因子-β和基质金属蛋白酶-7与子宫内膜异位症的相关研究.中国基层医药,2013,20:1310-1312. 11 冯春蝶,王福玲,袁芳,等.IL-17、IL-6和TGF-β在子宫内膜异位症患者组织的表达.中国免疫学杂志,2013,29:243-246. 12 郭丽娜,李芬.子宫内膜异位症中VEGF、MMP-2、TGF-β的表达及意义.中国美容医学,2012,21:233-234. 13 张名香,吴玲,顾莹,等.子宫内膜异位症患者治疗前后血清hs-CRP、CA125、TGF-β1和VEGF测定的临床意义.放射免疫学杂志,2012,25:457-459. 14 Wang XQ,Zhou WJ,Luo XZ,et al.Synergistic effect of regulatory T cells and proinflammatory cytokines in angiogenesis in the endometriotic milieu.Hum Reprod,2017,32:1304-1317. 15 Yu JJ,Sun HT,Zhang ZF,et al.IL-15 promotes growth and invasion of ESC and inhibits killing activity of NK cell in endometriosis.Reproduction,2016,152:151-160.